Keep in mind, that was 8 years ago too. And at the time, the company hinted that they got a great deal:
""The premium is not out of whack when you look at the scarcity value of this technology and the appetite for biotech companies right now," a source familiar with the deal told Reuters. "It's a small deal in size but a large deal in terms of the potential scope they gain with this science."
http://www.reuters.com/article/us-bristolmyers-idUSTRE56M07120090723
DXB Share Price, page-69
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $209.1M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.5¢ | 36.5¢ | $579.4K | 1.548M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 91570 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 7922 | 2 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| DXB (ASX) Chart |